Diagnosis and Treatment of Cutaneous Lymphoma

A World Leader in Cutaneous Lymphoma

The Stanford Multidisciplinary Cutaneous Lymphoma Clinic (CLC) is a leading center of excellence for managing patients with cutaneous lymphomas (lymphomas that arise in the skin); it also serves as a regional, national, and international referral center.

The majority of patients have mycosis fungoides, the most common type of cutaneous lymphoma. In the CLC we also evaluate and manage patients with other cutaneous lymphomas (B-cell lymphomas, CD30+ lymphomas, NK/T--cell lymphomas, panniculitis-like T-cell lymphomas, and other peripheral T-cell lymphomas). The clinic has been operating for over 30 years at Stanford with greater than 1000 patients seen.

Treatment Expertise

The cutaneous lymphoma team has achieved world-wide recognition for its success in managing patients with all of the cutaneous lymphomas.  Their experience includes the use of topical (nitrogen mustard) and systemic chemotherapy, biological therapies such as interferon and Targretin, light therapy such as PUVA and UVB, and radiation therapy including total skin electron beam therapy.

Clinic Information

The CLC is a multidisciplinary clinic that meets twice weekly and is co-attended by physicians from the departments of Dermatology, Radiation Oncology, Medical Oncology, and Dermatopathology. Clinicians have access to state-of-the art histochemical and molecular tools for diagnosis and patient management.

The clinic offers standard therapies and participation in investigative protocols, and provides patients with up-to-date information on cutaneous lymphomas and treatment alternatives. 

For New Patient referrals and appointments, please call (650) 498-6000, and the fax number for new patient referral is (650) 723-6956. For all other calls, please call (650) 498-6000.

Clinical Research

We have a wide variety of clinical research protocols available for patient management, including a variety of biological therapies such as immune stimulants, monocloncal antibodies, and vaccines. An integral part of our research is to track the long-term outcome of our patients.

The CLC has an on-going cutaneous lymphoma database dating back to the 1950’s with long-term follow-up as long as 50 years for some patients. Our mycosis fungoides database contains information about more than 700 patients.

We also have a separate database for CD30 (Ki-1) lymphoproliferative diseases and other cutaneous lymphomas. The databases, which are accessible only to authorized staff members, are centrally housed in the departments of Radiation Oncology and Dermatology and are updated by Dermatology staff. View more research information.

For more information about Cutaneous Lymphoma and the Stanford
Multidisciplinary Cutaneous Lymphoma group and their research, please
visit http://cutaneouslymphoma.stanford.edu.